• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种简单的系统,用于预测肝门部胆管癌的可切除性。

A simple system to predict perihilar cholangiocarcinoma resectability.

机构信息

Service de Chirurgie Hépatobiliaire et Digestive, Centre Hospitalier Universitaire de Rennes, Université de Rennes 1, Rennes, France.

出版信息

J Gastrointest Surg. 2013 Jul;17(7):1247-56. doi: 10.1007/s11605-013-2215-4. Epub 2013 May 9.

DOI:10.1007/s11605-013-2215-4
PMID:23657943
Abstract

BACKGROUND

The aim of this study was to retrospectively validate a new system to predict perihilar cholangiocarcinoma (PHC) resectability. We hypothesized that when the left lateral section (segments II-III) duct confluence (LLC) is free, the left lateral section might be preserved for curative resection. When the LLC is invaded, vascular invasion is frequent and radical resection might often be impossible without complex vascular reconstruction.

METHOD

Radiological files of patients operated for PHC at our institution were reviewed and PHC was classified depending on whether LLC was invaded (type X) or free (type Y). Peroperative findings and follow-up were then matched with our XY classification.

RESULTS

Thirty-seven patients were included, 28 (78 %) type Y and nine (22 %) type X PHCs. Hepatic artery (HA) invasion was present in 14 % of type Y and 100 % of type X PHCs (P < 0.001). Left HA was never involved in type Y and always involved in type X. Portal vein invasion was present in 25 and 78 % of type Y and type X PHC, respectively (P = 0.014). Complete resection rates without HA in type Y and X patients were 89 % (84 % R0 and 16 % R1) and 33 % (37.5 % R0 and 12.5 % R1), respectively (P = 0.01). Sensitivity, specificity, and precision of the XY classification to predict resectability were 84, 67, and 84 %, respectively.

CONCLUSION

XY classification for PHCs suggests that in type Y (free LLC), the tumor is most often resectable, while in type X (LLC involved), the tumor is only resectable using complex vascular reconstructions.

摘要

背景

本研究旨在回顾性验证一种新的系统来预测肝门部胆管癌(PHC)的可切除性。我们假设当左侧外侧段(II-III 段)胆管汇合(LLC)通畅时,左侧外侧段可能可以保留用于根治性切除。当 LLC 受侵犯时,常伴有血管侵犯,不进行复杂的血管重建则往往无法进行根治性切除。

方法

回顾性分析我院接受 PHC 手术的患者的影像学资料,并根据 LLC 是否受侵犯(X 型)或通畅(Y 型)对 PHC 进行分类。然后将术中发现和随访结果与我们的 XY 分类相匹配。

结果

共纳入 37 例患者,其中 28 例(78%)为 Y 型 PHC,9 例(22%)为 X 型 PHC。Y 型 PHC 肝动脉(HA)侵犯率为 14%,而 X 型 PHC 则为 100%(P<0.001)。Y 型中左 HA 从不受累,而 X 型中左 HA 总是受累。门静脉侵犯在 Y 型和 X 型 PHC 中的发生率分别为 25%和 78%(P=0.014)。Y 型和 X 型无 HA 患者的完全切除率分别为 89%(84%为 RO 切除,16%为 R1 切除)和 33%(37.5%为 RO 切除,12.5%为 R1 切除)(P=0.01)。XY 分类对可切除性的预测的敏感性、特异性和准确性分别为 84%、67%和 84%。

结论

PHC 的 XY 分类提示,在 Y 型(LLC 通畅)中,肿瘤通常可切除,而在 X 型(LLC 受侵犯)中,只有通过复杂的血管重建才能切除肿瘤。

相似文献

1
A simple system to predict perihilar cholangiocarcinoma resectability.一种简单的系统,用于预测肝门部胆管癌的可切除性。
J Gastrointest Surg. 2013 Jul;17(7):1247-56. doi: 10.1007/s11605-013-2215-4. Epub 2013 May 9.
2
Surgical implications of the confluence patterns of the left intrahepatic bile ducts in right hepatectomy for perihilar cholangiocarcinoma.肝门部胆管癌右半肝切除术中左肝内胆管汇合模式的手术意义
J Hepatobiliary Pancreat Sci. 2022 Apr;29(4):460-468. doi: 10.1002/jhbp.1044. Epub 2021 Sep 17.
3
Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection.肝内胆管癌:手术切除后的预后因素
World J Surg. 2009 Jun;33(6):1247-54. doi: 10.1007/s00268-009-9970-0.
4
Long-term outcome and prognostic factors of intrahepatic cholangiocarcinoma involving the hepatic hilus versus hilar cholangiocarcinoma after curative-intent resection: Should they be recognized as perihilar cholangiocarcinoma or differentiated?肝门部胆管癌累及肝门部与肝门部胆管癌根治性切除术后的长期预后和预后因素:是否应将其视为肝门周围胆管癌或加以区分?
Eur J Surg Oncol. 2019 Nov;45(11):2173-2179. doi: 10.1016/j.ejso.2019.06.014. Epub 2019 Jun 11.
5
Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma.225例肝门部胆管癌患者的分期、可切除性及预后
Ann Surg. 2001 Oct;234(4):507-17; discussion 517-9. doi: 10.1097/00000658-200110000-00010.
6
Hepatectomy with simultaneous resection of the portal vein and hepatic artery for advanced perihilar cholangiocarcinoma: an audit of 50 consecutive cases.肝切除术联合门静脉和肝动脉切除治疗高位肝门部胆管癌:50 例连续病例的回顾性分析。
Ann Surg. 2010 Jul;252(1):115-23. doi: 10.1097/SLA.0b013e3181e463a7.
7
Right hepatectomy for a detoured left hepatic artery in hilar cholangiocarcinoma-report of a rare but rational resection.肝门部胆管癌合并左肝动脉绕行的右半肝切除术——1例罕见但合理的肝切除报告
World J Surg Oncol. 2016 Nov 16;14(1):288. doi: 10.1186/s12957-016-1045-8.
8
[Evaluations of total hilar en bloc resection and reconstruction in comparison with portal vein resection and reconstruction in treatment of perihilar cholangiocarcinoma].[肝门部胆管癌治疗中全肝门整块切除重建与门静脉切除重建的对比评估]
Zhonghua Wai Ke Za Zhi. 2021 Jan 1;59(1):32-39. doi: 10.3760/cma.j.cn112139-20200728-00591.
9
Robotic Klatskin Type 3A Resection with Biliary Reconstruction: Description of Surgical Technique and Outcomes of Initial Series.机器人 Klatskin 型 3A 切除术联合胆道重建:手术技术描述及初步系列结果。
Ann Surg Oncol. 2023 Dec;30(13):8559-8560. doi: 10.1245/s10434-023-14256-y. Epub 2023 Sep 8.
10
Surgical treatment of hilar cholangiocarcinoma in the new era: the Asan experience.新时代肝门部胆管癌的外科治疗: 来自首尔峨山医院的经验。
J Hepatobiliary Pancreat Sci. 2010 Jul;17(4):476-89. doi: 10.1007/s00534-009-0204-5. Epub 2009 Oct 23.

引用本文的文献

1
Liver Resection for Type IV Perihilar Cholangiocarcinoma: Left or Right Trisectionectomy?IV型肝门部胆管癌的肝切除术:左半肝或右半肝三段切除术?
Cancers (Basel). 2022 Jun 4;14(11):2791. doi: 10.3390/cancers14112791.
2
Current Perspectives on the Surgical Management of Perihilar Cholangiocarcinoma.肝门部胆管癌外科治疗的现状
Cancers (Basel). 2022 Apr 28;14(9):2208. doi: 10.3390/cancers14092208.
3
The Surgical Management of Klatskin Tumours: Has Anything Changed in the Last Decade?肝门部胆管癌的外科治疗:过去十年有何变化?

本文引用的文献

1
Clinical significance of left trisectionectomy for perihilar cholangiocarcinoma: an appraisal and comparison with left hepatectomy.左三叶切除术治疗肝门周围胆管癌的临床意义:评价及与左半肝切除术的比较。
Ann Surg. 2012 Apr;255(4):754-62. doi: 10.1097/SLA.0b013e31824a8d82.
2
Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings.右门静脉结扎联合原位劈裂诱导快速左外侧肝叶肥大,使小肝体积下 2 期扩大右半肝切除术成为可能。
Ann Surg. 2012 Mar;255(3):405-14. doi: 10.1097/SLA.0b013e31824856f5.
3
World J Surg. 2015 Nov;39(11):2748-56. doi: 10.1007/s00268-015-3125-2.
4
Clinical significance of anatomical variant of the left hepatic artery for perihilar cholangiocarcinoma applied to right-sided hepatectomy.肝门部胆管癌左肝动脉解剖变异在右侧肝切除术中的临床意义
World J Surg. 2014 Dec;38(12):3210-4. doi: 10.1007/s00268-014-2715-8.
5
An update on liver surgery for cholangiocarcinoma.胆管癌的肝外科治疗进展。
Updates Surg. 2014 Jun;66(2):93-100. doi: 10.1007/s13304-013-0235-y. Epub 2013 Oct 2.
Klatskin tumors and the accuracy of the Bismuth-Corlette classification.
肝门部胆管癌与比绍特-科莱特分类法的准确性
Am Surg. 2011 Dec;77(12):1695-9.
4
Oncological superiority of hilar en bloc resection for the treatment of hilar cholangiocarcinoma.肝门整块切除术治疗肝门部胆管癌的肿瘤学优势。
Ann Surg Oncol. 2012 May;19(5):1602-8. doi: 10.1245/s10434-011-2077-5. Epub 2011 Oct 1.
5
Role of preoperative optimization of the liver for resection in patients with hilar cholangiocarcinoma type III.肝门部胆管癌 III 型患者肝切除术前肝脏优化的作用。
Ann Surg Oncol. 2010 Dec;17(12):3155-61. doi: 10.1245/s10434-010-1168-z. Epub 2010 Jul 1.
6
Aggressive surgical resection for hilar cholangiocarcinoma of the left-side predominance: radicality and safety of left-sided hepatectomy.左侧优势性肝门部胆管癌的积极外科切除术:左半肝切除术的根治性和安全性。
Ann Surg. 2010 Feb;251(2):281-6. doi: 10.1097/SLA.0b013e3181be0085.
7
Surgical treatment of hilar cholangiocarcinoma in the new era: the Asan experience.新时代肝门部胆管癌的外科治疗: 来自首尔峨山医院的经验。
J Hepatobiliary Pancreat Sci. 2010 Jul;17(4):476-89. doi: 10.1007/s00534-009-0204-5. Epub 2009 Oct 23.
8
Clinical value of additional resection of a margin-positive proximal bile duct in hilar cholangiocarcinoma.肝门部胆管癌切缘阳性近端胆管附加切除的临床价值。
Surgery. 2010 Jan;147(1):49-56. doi: 10.1016/j.surg.2009.06.030. Epub 2009 Sep 20.
9
Hilar cholangiocarcinoma: current management.肝门部胆管癌:当前的治疗方法
Ann Surg. 2009 Aug;250(2):210-8. doi: 10.1097/SLA.0b013e3181afe0ab.
10
The concept of perihilar cholangiocarcinoma is valid.肝门周围胆管癌的概念是有效的。
Br J Surg. 2009 Aug;96(8):926-34. doi: 10.1002/bjs.6655.